Recruiting
Phase 1
Phase 2

Ribociclib and Bicalutamide in AR+ TNBC

Sponsor:

Kari Wisinski

Code:

NCT03090165

Conditions

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ribociclib

ribociclib

Bicalutamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information